Timo Minssen is Professor of Law at the University of Copenhagen (UCPH). He is the Director of UCPH’s Center for Advanced Studies in Bioscience Innovation Law (CeBIL) and holds the UNESCO Co-Chair in the Right to Science. Timo is also an Inter-CeBIL Research Affiliate at Harvard Law School and at the University of Cambridge, as well as an Associate Member of the Centre of Genomics and Policy at McGill University. His research and practice concentrate on IP-, Competition & Regulatory Law in emerging technologies, including the law and ethics of AI, quantum technologies, and health & life science innovation.
Timo holds a German law degree from the University of Göttingen, and biotech and IP-related LL.M. M.I.C.L., LL.Lic., and LL.D. degrees from Lund and Uppsala University. Previously, he was an Epigenetics fellow at the Pufendorf Institute for Advanced Studies and Visiting Professor at the Technical University of Munich, the Universities of Cambridge and Oxford, Waseda Law School, Harvard Law School, and the Max Planck Institute for Innovation and Competition. In 2007, he also held the position of Associate Professor at the Chicago-Kent College of Law, teaching a course in comparative European and US patent law. Moreover, he was trained in the German Court system, the European Patent Office, law firms, and start-ups.
Timo is Scientific Advisory Board Member of the Munich Intellectual Property Law Centre (MIPLC). He also serves as an advisor to the WHO, WIPO, OECD, the EU Commission, companies, national governments, and law firms. At UCPH he leads several interdisciplinary research projects on legal issues in emerging biotechnologies, precision medicine, ATMPs, antimicrobial resistance, pandemic preparedness, advanced medical computing, medical devices, and in sustainable innovation. He is the PI and grant holder of a large research program in bioscience innovation law, funded by the Novo Nordisk Foundation and involving international core partners, such as Harvard, DTU, and the Universities of Cambridge and Michigan.His research comprises 8 books and 260+ publications in leading law and science journals. It is frequently featured in international media, such as The Economist, Financial Times, El Mundo, Politico, Times of India, WHO Bulletin, and Times Higher Education.
